Your browser doesn't support javascript.
loading
The Role of Astrocytes in Synapse Loss in Alzheimer's Disease: A Systematic Review.
Hulshof, Lianne A; van Nuijs, Danny; Hol, Elly M; Middeldorp, Jinte.
Afiliación
  • Hulshof LA; Department of Translational Neuroscience, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, Netherlands.
  • van Nuijs D; Department of Translational Neuroscience, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, Netherlands.
  • Hol EM; Department of Translational Neuroscience, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, Netherlands.
  • Middeldorp J; Department of Translational Neuroscience, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, Netherlands.
Front Cell Neurosci ; 16: 899251, 2022.
Article en En | MEDLINE | ID: mdl-35783099
ABSTRACT
Alzheimer's disease (AD) is the most common cause of dementia, affecting 35 million people worldwide. One pathological feature of progressing AD is the loss of synapses. This is the strongest correlate of cognitive decline. Astrocytes, as an essential part of the tripartite synapse, play a role in synapse formation, maintenance, and elimination. During AD, astrocytes get a reactive phenotype with an altered gene expression profile and changed function compared to healthy astrocytes. This process likely affects their interaction with synapses. This systematic review aims to provide an overview of the scientific literature including information on how astrocytes affect synapse formation and elimination in the brain of AD patients and in animal models of the disease. We review molecular and cellular changes in AD astrocytes and conclude that these predominantly result in lower synapse numbers, indicative of decreased synapse support or even synaptotoxicity, or increased elimination, resulting in synapse loss, and consequential cognitive decline, as associated with AD. Preventing AD induced changes in astrocytes might therefore be a potential therapeutic target for dementia. Systematic Review Registration https//www.crd.york.ac.uk/prospero/display_record.php?RecordID=148278, identifier [CRD148278].
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Front Cell Neurosci Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Front Cell Neurosci Año: 2022 Tipo del documento: Article